Benign prostatic hyperplasia. Hyperplasia of prostate
Conditions
Interventions
Intervention 1: In the intervention group after removing the prostatic adenoma, 20 ml of 0.5% bupivacaine will be injected in the posterior prostatic capsule from 4 to 8 o clock. Intervention 2: In th
Prevention
Placebo
In the intervention group after removing the prostatic adenoma, 20 ml of 0.5% bupivacaine will be injected in the posterior prostatic capsule from 4 to 8 o clock.
In the control group after removing the prostatic adenoma, 20 ml of normal saline will be injected in the posterior prostatic capsule from 4 to 8 o clock.
Sponsors
Vice chancellor for research, Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
55 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients who are candidate for open prostatectomy due to obstructive urinary symptom and do not have allergy to bupivacaine Exclusion criteria: Prostatic capsule perforation during the surgery
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of pethidine used. Timepoint: Every our in the first 8 hours from the surgery and then every 3 hours therafter up to 24 hours. Method of measurement: The amount of used drug in miligram.;Amount of pain. Timepoint: Every our in the first 8 hours from the surgery and then every 3 hours therafter up to 24 hours. Method of measurement: Based on pain visual analog scale which is filled by the patient from 0 to 10. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: 24 hours after the surgery. Method of measurement: Any changes in blood pressure and cardiac arrhythmias. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Dinyar Khazaeli
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed